48 related articles for article (PubMed ID: 3920969)
1. [The effect of calcium antagonists on intracellular transport of epidermal growth factor and the conjugate of epidermal growth factor with pseudomonas exotoxin].
Akiyama S
Gan To Kagaku Ryoho; 1985 Mar; 12(3 Pt 2):660-8. PubMed ID: 3920969
[TBL] [Abstract][Full Text] [Related]
2. Verapamil enhances the toxicity of conjugates of epidermal growth factor with Pseudomonas exotoxin and antitransferrin receptor with Pseudomonas exotoxin.
Akiyama S; Gottesman MM; Hanover JA; Fitzgerald DJ; Willingham MC; Pastan I
J Cell Physiol; 1984 Sep; 120(3):271-9. PubMed ID: 6086678
[TBL] [Abstract][Full Text] [Related]
3. The effect of calcium antagonists on the proteolytic degradation of low-density lipoprotein in HeLa cells.
Akiyama S; Tomita K; Kuwano M
Exp Cell Res; 1985 May; 158(1):192-204. PubMed ID: 3888644
[TBL] [Abstract][Full Text] [Related]
4. Interference of the calcium antagonists verapamil and nifedipine with lysosomal enzyme release from rabbit polymorphonuclear leukocytes.
Elferink JG
Arzneimittelforschung; 1982; 32(11):1417-20. PubMed ID: 6891245
[TBL] [Abstract][Full Text] [Related]
5. Isolation of human KB cell lines resistant to epidermal growth factor-Pseudomonas exotoxin conjugates.
Lyall RM; Hwang JL; Cardarelli C; FitzGerald D; Akiyama S; Gottesman MM; Pastan I
Cancer Res; 1987 Jun; 47(11):2961-6. PubMed ID: 3494506
[TBL] [Abstract][Full Text] [Related]
6. Thioridazine enhances lysosomal accumulation of epidermal growth factor and toxicity of conjugates of epidermal growth factor with Pseudomonas exotoxin.
Kuratomi Y; Akiyama S; Ono M; Shiraishi N; Shimada T; Ohkuma S; Kuwano M
Exp Cell Res; 1986 Feb; 162(2):436-48. PubMed ID: 3484705
[TBL] [Abstract][Full Text] [Related]
7. Calcium antagonists potentiate P-glycoprotein-independent anticancer drugs in chronic lymphocytic leukemia cells in vitro.
Vilpo J; Koski T; Vilpo L
Haematologica; 2000 Aug; 85(8):806-13. PubMed ID: 10942926
[TBL] [Abstract][Full Text] [Related]
8. Role of the microtubule cytoskeleton in traffic of EGF through the lacrimal acinar cell endomembrane network.
Xie J; Qian L; Wang Y; Hamm-Alvarez SF; Mircheff AK
Exp Eye Res; 2004 Jun; 78(6):1093-106. PubMed ID: 15109916
[TBL] [Abstract][Full Text] [Related]
9. Potentiation of cytotoxic activity of immunotoxins on cultured human cells.
Akiyama S; Seth P; Pirker R; FitzGerald D; Gottesman MM; Pastan I
Cancer Res; 1985 Mar; 45(3):1005-7. PubMed ID: 2982480
[TBL] [Abstract][Full Text] [Related]
10. Involvement of multiple subcellular compartments in intracellular processing of epidermal growth factor.
Miskimins WK; Shimizu N
J Cell Biochem; 1982; 20(1):41-50. PubMed ID: 6984446
[TBL] [Abstract][Full Text] [Related]
11. Subcellular structures involved in internalization and degradation of epidermal growth factor.
Fine RE; Goldenberg R; Sorrentino J; Herschman HR
J Supramol Struct Cell Biochem; 1981; 15(3):235-51. PubMed ID: 6267315
[TBL] [Abstract][Full Text] [Related]
12. Cysteine proteinases in GH4C1 cells, a rat pituitary tumor cell line, are secreted by the constitutive and regulated secretory pathways.
Waguri S; Sato N; Watanabe T; Ishidoh K; Kominami E; Sato K; Uchiyama Y
Eur J Cell Biol; 1995 Aug; 67(4):308-18. PubMed ID: 8521870
[TBL] [Abstract][Full Text] [Related]
13. Verapamil inhibits proliferation, migration and protein kinase C activity in human retinal pigment epithelial cells.
Hoffman S; Gopalakrishna R; Gundimeda U; Murata T; Spee C; Ryan SJ; Hinton DR
Exp Eye Res; 1998 Jul; 67(1):45-52. PubMed ID: 9702177
[TBL] [Abstract][Full Text] [Related]
14. Dual pathways for epidermal growth factor processing after receptor-mediated endocytosis.
Miskimins WK; Shimizu N
J Cell Physiol; 1982 Sep; 112(3):327-38. PubMed ID: 6290503
[TBL] [Abstract][Full Text] [Related]
15. Uptake of epidermal growth factor into a lysosomal enzyme-deficient organelle: correlation with cell's mitogenic response and evidence for ubiquitous existence in fibroblasts.
Miskimins WK; Shimizu N
J Cell Physiol; 1984 Mar; 118(3):305-16. PubMed ID: 6607926
[TBL] [Abstract][Full Text] [Related]
16. Voltage clamp comparison of the organic calcium channel blockers D-600 and nisoldipine.
Uehara A; Hume JR
Proc West Pharmacol Soc; 1984; 27():343-7. PubMed ID: 6494173
[No Abstract] [Full Text] [Related]
17. Intracellular processing of 125I-epidermal growth factor in rat embryo fibroblasts.
Magun BE; Planck SR; Wagner HN
J Cell Biochem; 1982; 20(3):259-76. PubMed ID: 6984857
[TBL] [Abstract][Full Text] [Related]
18. Changes in sphingolipid levels induced by epidermal growth factor in osteoblastic cells. Effects of these metabolites on cytosolic calcium levels.
Carpio LC; Shiau H; Dziak R
Prostaglandins Leukot Essent Fatty Acids; 2000 Apr; 62(4):225-32. PubMed ID: 10882186
[TBL] [Abstract][Full Text] [Related]
19. Zeta isoform of protein kinase C prevents oxidant-induced nuclear factor-kappaB activation and I-kappaBalpha degradation: a fundamental mechanism for epidermal growth factor protection of the microtubule cytoskeleton and intestinal barrier integrity.
Banan A; Fields JZ; Zhang LJ; Shaikh M; Farhadi A; Keshavarzian A
J Pharmacol Exp Ther; 2003 Oct; 307(1):53-66. PubMed ID: 12893839
[TBL] [Abstract][Full Text] [Related]
20. Enhancement by a synthetic isoprenoid of the toxicity of conjugates of epidermal growth factor with Pseudomonas exotoxin.
Akiyama S; Shiraishi N; Yoshimura A; Nakagawa M; Yamaguchi T; Shimada T; Kuwano M
Biochem Pharmacol; 1987 Mar; 36(6):861-8. PubMed ID: 3494452
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
